Access to qualitative sample and data collections can be very valuable tools in R&D, paving the way for new medicines, treatments and medical products. Access can, however, be perceived complicated. Through the “Biobanks and Health Data Registers” strategic initiative, EIT Health Scandinavia aims to accelerate the use of big data, biobanks and health data registries in development of new healthcare solutions. The initiative seeks to address several issues which hinders the Partners from leveraging the Scandinavian and Estonian assets in biobanks and health data collections, including simplifying access, in order to gain improvements for R&D and to implement new innovations faster into the market.